Anti-ORF7a (SARS-CoV-2) Polyclonal Antibody | AB0409

Goat Anti-SARS-CoV-2 ORF7a (SARS-CoV-2) IgG Polyclonal Antibody | AB0409 | Antibodies

Overview: ORF7a is a SARS-CoV accessory protein that is composed of a type I transmembrane protein that localizes primarily to the Golgi apparatus and also be found on the cell surface. This protein has been implicated on several mechanisms such as suppressing both transgene and virus-induced gene silencing by reducing the levels of small interfering RNA (siRNA), attachment and modulation of leukocytes by biding to host ITGAL and playing a role as antagonist of host tetherin (BST2) by disrupting its antiviral effect.

Other Names: ORF7a SARS Coronavirus-2 antibody.

Other Names: ORF7a SARS Coronavirus-2 antibody.

Concentration: 3 mg/ml

Antibody Type: Primary

Target Type: anti-ORF7a (SARS-CoV-2)

Accession Number: N/A

Host Species: Goat

Immunogen Species: SARS-CoV-2

Immunogen Type: Recombinant protein

Immunogen: Affinity purified recombinant fusion protein ORF7a (residues 18 to 95) produced in E. coli.

Isotype: IgG

Clonality: Polyclonal

Confirmed Reactive Species: Reacts with SARS-CoV-2 protein

Specificity Detail: In lysates of transfected cells with the plasmid containing the sequence used, detects the fusion protein by Western blot.

Buffer: PBS, 20% glycerol and 0.05% sodium azide

Purification: Epitope affinity purified

Conjugation: Unconjugated

Format: N/A

Application: WB

Concentration/Dilution: WB:1:500-1:2,000

Storage: N/A

References: N/A